Trial · NCT00819052
Adverse events302
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 302
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Conjunctivitis | Eye disorders | Nevirapine Immediate Release (NVP IR) | 8 | 148 | |
| other | Conjunctivitis | Eye disorders | Nevirapine Extended Release (NVP XR) | 11 | 295 | |
| other | Diarrhoea | Gastrointestinal disorders | Nevirapine Immediate Release (NVP IR) | 20 | 148 | |
| other | Diarrhoea | Gastrointestinal disorders | Nevirapine Extended Release (NVP XR) | 62 | 295 | |
| other | Gastrooesophageal reflux disease | Gastrointestinal disorders | Nevirapine Immediate Release (NVP IR) | 2 | 148 | |
| other | Gastrooesophageal reflux disease | Gastrointestinal disorders | Nevirapine Extended Release (NVP XR) | 16 | 295 | |
| other | Nausea | Gastrointestinal disorders | Nevirapine Immediate Release (NVP IR) | 4 | 148 | |
| other | Nausea | Gastrointestinal disorders | Nevirapine Extended Release (NVP XR) | 20 | 295 | |
| other | Fatigue | General disorders | Nevirapine Immediate Release (NVP IR) | 9 | 148 | |
| other | Fatigue | General disorders | Nevirapine Extended Release (NVP XR) | 30 | 295 | |
| other | Bronchitis | Infections and infestations | Nevirapine Immediate Release (NVP IR) | 24 | 148 | |
| other | Bronchitis | Infections and infestations | Nevirapine Extended Release (NVP XR) | 49 | 295 | |
| other | Gastroenteritis | Infections and infestations | Nevirapine Immediate Release (NVP IR) | 12 | 148 | |
| other | Gastroenteritis | Infections and infestations | Nevirapine Extended Release (NVP XR) | 16 | 295 | |
| other | Herpes zoster | Infections and infestations | Nevirapine Immediate Release (NVP IR) | 3 | 148 | |
| other | Herpes zoster | Infections and infestations | Nevirapine Extended Release (NVP XR) | 15 | 295 | |
| other | Nasopharyngitis | Infections and infestations | Nevirapine Immediate Release (NVP IR) | 25 | 148 | |
| other | Nasopharyngitis | Infections and infestations | Nevirapine Extended Release (NVP XR) | 74 | 295 | |
| other | Pharyngitis | Infections and infestations | Nevirapine Immediate Release (NVP IR) | 10 | 148 | |
| other | Pharyngitis | Infections and infestations | Nevirapine Extended Release (NVP XR) | 16 | 295 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00819052/events